Universitätsklinikum Frankfurt am Main (KGU)

Final Results of a Non-Interventional Study Evaluating the Quality of Life in Second-line Treatment of Metastatic Renal Cell Carcinoma With Everolimus: The EVERPRO Study (2019) Goebell P, Hermann E, Kube U, Doehn C, Marschner N, Dietel A, Blumenstengel K, et al. Journal article High proliferation rate and TNM stage but not histomorphological subtype are independent prognostic markers for overall survival in papillary renal cell carcinoma (2019) Polifka I, Agaimy A, Herrmann E, Spath V, Trojan L, Stoeckle M, Becker F, et al. Journal article A randomized controlled trial of the effect of spironolactone on left ventricular mass in hemodialysis patients (2019) Hammer F, Malzahn U, Donhauser J, Betz C, Schneider M, Grupp C, Pollak N, et al. Journal article Biology-driven approaches to prevent and treat relapse of myeloid neoplasia after allogeneic hematopoietic stem cell transplantation (2019) Zeiser R, Beelen DW, Bethge W, Bornhäuser M, Bug G, Burchert A, Christopeit M, et al. Journal article Psychosocial distress and utilization of professional psychological care in cancer patients: An observational study in National Comprehensive Cancer Centers (CCCs) in Germany. (2018) Weis J, Hoenig K, Bergelt C, Faller HH, Brechtel A, Hornemann B, Stein B, et al. Journal article EZH2 Mutations and Impact on Clinical Outcome Analyzed in 1604 Patients with Acute Myeloid Leukemia (2018) Stasik S, Middeke JM, Kraemer M, Rollig C, Kramer A, Scholl S, Hochhaus A, et al. Conference contribution Prospective Clinical Phase II Results on Treosulfan-Based Conditioning Treatment of 70 Paediatric Patients with Haematological Malignancies (2018) Kalwak K, Bader P, Styczynski J, Gruhn B, Patrick K, Sedlacek P, Stachel D, et al. Conference contribution SOCIO-ECONOMIC IMPACT OF DRAVET SYNDROME IN GERMANY: A REAL-WORLD STUDY (2018) Irwin J, Strzelczyk A, Kalski M, Bast T, Wiemer-Kruel A, Bettendorf U, Kieslich M, et al. Conference contribution Evaluation of the MammaTyperVR as a molecular predictor for pathological complete response (pCR) after neoadjuvant chemotherapy (NACT) and outcome in patients with different breast cancer (BC) subtypes (2018) Fasching P, Laible M, Weber KE, Wirtz RM, Denkert C, Schlombs K, Schmatloch S, et al. Conference contribution Validation of the MammaTyper (R) pathological complete response (pCR)-score as a predictor for response after neoadjuvant chemotherapy (NACT) in patients with early breast cancer (BC) (2018) Fasching P, Laible M, Weber KE, Wirtz RM, Denkert C, Schlombs K, Schmatloch S, et al. Conference contribution